NCT01933360View on ClinicalTrials.gov

Misoprostol for Cervical Priming Prior to Vacuum Aspiration

PHASE2CompletedINTERVENTIONAL
Enrollment

184

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
First Trimester PregnancySurgical Termination of Pregnancy
Interventions
DRUG

Misoprostol sublingual, 1h

Misoprostol is administered sublingually 1 hour prior to surgical termination of early pregnancy

DRUG

Placebo sublingual,1h

Placebo for misoprostol is administered sublingually 1 hour prior to surgical termination of early pregnancy

DRUG

Misoprostol sublingual, 3h

Misoprostol is administered sublingually, 3 hours prior to surgical termination of early pregnancy

DRUG

Misoprostol vaginal, 1h

Misoprostol is administered vaginally 1 hour prior to surgical termination of early pregnancy

DRUG

Misoprostol vaginal, 3h

Misoprostol is administered vaginally 3 hours prior to surgical termination of early pregnancy

DRUG

Placebo sublingual, 3h

Placebo for misoprostol is administered sublingually 3 hours prior to surgical termination of early pregnancy

DRUG

Placebo vaginal, 1h

Placebo for misoprostol is administered vaginally 1 hour prior to surgical termination of early pregnancy

DRUG

Placebo vaginal, 3h

Placebo for misoprostol is administered vaginally 3 hours prior to surgical termination of early pregnancy

Trial Locations (1)

17176

Karolinska University Hospital, Stockholm

All Listed Sponsors
lead

Karolinska Institutet

OTHER

NCT01933360 - Misoprostol for Cervical Priming Prior to Vacuum Aspiration | Biotech Hunter | Biotech Hunter